The ubiquitin-proteasome pathway and endothelial (dys)function

Regulation and Cellular Roles of Ubiquitin-Specific Deubiquitinating Enzymes

(2009) Francisca E. Reyes-Turcu et al.   Annual Review of Biochemistry

Endothelium-dependent contractions in SHR: a tale of prostanoid TP and IP receptors

(2009) Michel Félétou et al.   BRITISH JOURNAL OF PHARMACOLOGY

Protection of vascular cells from oxidative stress by proteasome inhibition depends on Nrf2

(2009) Henryk Dreger et al.   CARDIOVASCULAR RESEARCH

CHIP facilitates ubiquitination of inducible nitric oxide synthase and promotes its proteasomal degradation

(2009) Li Chen et al.   CELLULAR IMMUNOLOGY

COX-1 and Vascular Disease

(2009) P M Vanhoutte   CLINICAL PHARMACOLOGY & THERAPEUTICS

Degradation of FAT10 by the 26S proteasome is independent of ubiquitylation but relies on NUB1L

(2009) Gunter Schmidtke et al.   FEBS LETTERS

Tyrosine Nitration of PA700 Activates the 26S Proteasome to Induce Endothelial Dysfunction in Mice With Angiotensin II–Induced Hypertension

(2009) Jian Xu et al.   HYPERTENSION

Rab1 GTPase and Dimerization in the Cell Surface Expression of Angiotensin II Type 2 Receptor

(2009) X. Zhang et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Proteasome inhibition prevents experimentally-induced endothelial dysfunction

(2009) Mario Lorenz et al.   LIFE SCIENCES

Origin and function of ubiquitin-like proteins

(2009) Mark Hochstrasser   NATURE

Prostanoids and reactive oxygen species: Team players in endothelium-dependent contractions

(2009) Eva H.C. Tang et al.   PHARMACOLOGY & THERAPEUTICS

Targeting Proteins for Destruction by the Ubiquitin System: Implications for Human Pathobiology

(2008) Alan L. Schwartz et al.   Annual Review of Pharmacology and Toxicology

Endothelial Dysfunction: From Molecular Mechanisms to Measurement, Clinical Implications, and Therapeutic Opportunities

(2008) Michelle Le Brocq et al.   ANTIOXIDANTS & REDOX SIGNALING

Regulation of proteasome-mediated protein degradation during oxidative stress and aging

(2008) Nicolle Breusing et al.   BIOLOGICAL CHEMISTRY

Oxidative stress and COX cause hyper-responsiveness in vascular smooth muscle of the femoral artery from diabetic rats

(2008) Y Shi et al.   BRITISH JOURNAL OF PHARMACOLOGY

Targeting of the Proteasome Worsens Atherosclerosis?

(2008) Antje Ludwig et al.   CIRCULATION RESEARCH

Cyclooxygenase-2–Derived Prostaglandin F 2α Mediates Endothelium-Dependent Contractions in the Aortae of Hamsters With Increased Impact During Aging

(2008) Siu Ling Wong et al.   CIRCULATION RESEARCH

Contribution of endothelium-derived hyperpolarizing factors to the regulation of vascular tone in humans

(2008) Jeremy Bellien et al.   FUNDAMENTAL & CLINICAL PHARMACOLOGY

Role of S3 and S4 Transmembrane Domain Charged Amino Acids in Channel Biogenesis and Gating of KCa2.3 and KCa3.1

(2008) Yajuan Gao et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Mass Spectrometric Analysis of Type 1 Inositol 1,4,5-Trisphosphate Receptor Ubiquitination

(2008) Danielle A. Sliter et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Two Distinct Pathways for Cyclooxygenase-2 Protein Degradation

(2008) Uri R. Mbonye et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

The persisting challenge of selective and specific proteasome inhibition

(2008) Michael Groll et al.   JOURNAL OF PEPTIDE SCIENCE

Possible Dual Role of Ubiquitin-Proteasome System in the Atherosclerotic Plaque Progression

(2008) Clara Di Filippo et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Vascular protection by tetrahydrobiopterin: progress and therapeutic prospects

(2008) Zvonimir S. Katusic et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

Endothelial nitric oxide (NO) and its pathophysiologic regulation

(2008) Anuran Chatterjee et al.   VASCULAR PHARMACOLOGY

Oxidative stress in vascular disease: causes, defense mechanisms and potential therapies

(2008) Ulrich Förstermann   Nature clinical practice. Cardiovascular medicine

Proteasome inhibitors: Poisons and remedies

(2007) Silke Meiners et al.   MEDICINAL RESEARCH REVIEWS